Alopecia Areata

Lilly Receives FDA Breakthrough Therapy Designation for Baricitinib for the Treatment of Alopecia Areata (March 16, 2020).

Recognition reinforces baricitinib’s potential to be the first FDA-approved medicine for individuals living with alopecia areata.